| pubmed-article:1691013 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1691013 | lifeskim:mentions | umls-concept:C0011615 | lld:lifeskim |
| pubmed-article:1691013 | lifeskim:mentions | umls-concept:C0221912 | lld:lifeskim |
| pubmed-article:1691013 | lifeskim:mentions | umls-concept:C0019588 | lld:lifeskim |
| pubmed-article:1691013 | lifeskim:mentions | umls-concept:C0038585 | lld:lifeskim |
| pubmed-article:1691013 | lifeskim:mentions | umls-concept:C0443286 | lld:lifeskim |
| pubmed-article:1691013 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:1691013 | pubmed:dateCreated | 1990-5-18 | lld:pubmed |
| pubmed-article:1691013 | pubmed:abstractText | The flare and weal reactions to intradermal injections of histamine and the peptide substance P were measured in a group of patients with atopic dermatitis and compared to reactions in a non-atopic control group. There was no significant difference in the flare areas between the controls and atopics with either reagent. The weal volumes after injection of substance P and histamine were significantly larger in the atopic group. As substance P causes mast cell histamine release, the increased weal volumes produced by substance P in the atopics may be entirely due to the exaggerated atopic weal reaction to histamine. | lld:pubmed |
| pubmed-article:1691013 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1691013 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1691013 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1691013 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1691013 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1691013 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1691013 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:1691013 | pubmed:issn | 0007-0963 | lld:pubmed |
| pubmed-article:1691013 | pubmed:author | pubmed-author:HoldenC ACA | lld:pubmed |
| pubmed-article:1691013 | pubmed:author | pubmed-author:CoulsonI HIH | lld:pubmed |
| pubmed-article:1691013 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1691013 | pubmed:volume | 122 | lld:pubmed |
| pubmed-article:1691013 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1691013 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1691013 | pubmed:pagination | 343-9 | lld:pubmed |
| pubmed-article:1691013 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:meshHeading | pubmed-meshheading:1691013-... | lld:pubmed |
| pubmed-article:1691013 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:1691013 | pubmed:articleTitle | Cutaneous reactions to substance P and histamine in atopic dermatitis. | lld:pubmed |
| pubmed-article:1691013 | pubmed:affiliation | Skin Laboratory, St Helier Hospital, Carshalton, Surrey, U.K. | lld:pubmed |
| pubmed-article:1691013 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1691013 | pubmed:publicationType | Comparative Study | lld:pubmed |
